- Home
- NFG vs CORT Comparison
NFG vs CORT Comparison
Compare NFG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFG
- CORT
- Stock Information
- Founded
- NFG 1902
- CORT 1998
- Country
- NFG United States
- CORT United States
- Employees
- NFG N/A
- CORT N/A
- Industry
- NFG Oil/Gas Transmission
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- NFG Utilities
- CORT Health Care
- Exchange
- NFG Nasdaq
- CORT Nasdaq
- Market Cap
- NFG 7.7B
- CORT 8.8B
- IPO Year
- NFG N/A
- CORT N/A
- Fundamental
- Price
- NFG $82.00
- CORT $72.81
- Analyst Decision
- NFG Hold
- CORT Strong Buy
- Analyst Count
- NFG 5
- CORT 4
- Target Price
- NFG $91.20
- CORT $139.00
- AVG Volume (30 Days)
- NFG 557.9K
- CORT 947.2K
- Earning Date
- NFG 11-06-2025
- CORT 10-29-2025
- Dividend Yield
- NFG 2.61%
- CORT N/A
- EPS Growth
- NFG N/A
- CORT N/A
- EPS
- NFG 2.67
- CORT 1.11
- Revenue
- NFG $2,183,330,000.00
- CORT $716,080,000.00
- Revenue This Year
- NFG $21.25
- CORT $30.77
- Revenue Next Year
- NFG $17.68
- CORT $37.75
- P/E Ratio
- NFG $30.76
- CORT $65.48
- Revenue Growth
- NFG 12.45
- CORT 25.71
- 52 Week Low
- NFG $58.82
- CORT $42.01
- 52 Week High
- NFG $94.13
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- NFG 33.27
- CORT 39.30
- Support Level
- NFG $81.66
- CORT $69.43
- Resistance Level
- NFG $86.76
- CORT $80.29
- Average True Range (ATR)
- NFG 1.85
- CORT 4.38
- MACD
- NFG -0.63
- CORT -1.33
- Stochastic Oscillator
- NFG 4.35
- CORT 15.65
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.